-
This paper reports the results of a prospective study of patients aged 50 years and older with acute isolated third, fourth, and sixth nerve palsies.
-
Barnett and Prineas describe the pathological and clinical findings in 12 patients with relapsing-remitting multiple sclerosis, who died shortly after the onset of a relapse.
-
Does prednisone, administered early in the course of ocular myasthenia, affect its progression to generalized disease?
-
The National Cholesterol Education Program, a product of a collaboration of the National Heart, Lung, and Blood Institutes, the American College of Cardiology, and the American Heart Association, has updated its clinical practice guideline on cholesterol management.
-
-
The hundreds of presentations at this meeting provided encouraging evidence that existing Alzheimers therapies may have greater benefits than first realized, and that a new generation of potential disease-modifying therapies for AD may be on the way.
-
It seems prudent to strongly consider use of melatonin in our cognitively delayed patients with disordered sleep, but to monitor those with epilepsy very closely for exacerbation, and withdraw the drug.
-
These studies provide additional data about the higher risk of relapse, and the greater potential for progression of disability following childbirth.
-
Absence of evidence-based medicine is both humbling, as well as a reminder of how substantial a role the art and oral tradition of medicine plays in the care of neurologic patients.
-
Methylprednisolone significantly improves the recovery of peripheral vestibular function in patients with vestibular neuritis, whereas valacyclovir does not.
